Ohr Pharmaceutical to present interim data from ongoing Phase II clinical trial of OHR/AVR118

NewsGuard 100/100 Score
Dec 2 2009

Ohr Pharmaceutical Inc. (OTCBB: OHRP), announced that interim data from the company's ongoing Phase II clinical trial of OHR/AVR118 for the treatment of Cachexia, will be presented at the 5th annual meeting of the Society on Cachexia and Wasting Disorders (SCWD), which will be held in Barcelona December 5 - December 8, 2009.

The abstract was selected for oral presentation on Monday, December 7, 2009 in the "Clinical Trials: late-breaking approaches" session.

Source:

Ohr Pharmaceutical Inc.

Posted in: Drug Trial News

Tags: , , ,

Comments (0)

Suggested Reading

Esketamine after childbirth cuts risk of postnatal depression by three-quarters
Common HIV drugs linked to reduced Alzheimer's disease risk
Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance
Natural obesity fighters: How coffee, tea, and cocoa combat weight gain
Study highlights global fertility decline and its implications for the future
New urine-based test improves identification of high-grade prostate cancer
Reduction of prenatal depression associated with higher full-term birth rates
The Lancet Breast Cancer Commission: Tackling inequalities, hidden costs, and empowering patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Mediterranean diet and exercise reshape gut microbiome, aiding weight loss